CPC Pain & Wellness SPV, LLC Takes 10% Stake in XWELL, Inc.

TL;DR

**XWELL:** CPC Pain & Wellness SPV, LLC now owns 10%!

AI Summary

On June 17, 2024, CPC Pain & Wellness SPV, LLC, along with Wayne Mack and Richard Waldo, filed an SC 13D, indicating they collectively beneficially own 10.0% of XWELL, Inc. common stock. This filing suggests a significant stake and potential for influence over the company's direction.

Why It Matters

This filing signals a substantial investment by CPC Pain & Wellness SPV, LLC, potentially leading to changes in XWELL, Inc.'s strategy or management.

Risk Assessment

Risk Level: medium — A 10% stake by a new entity can signal activist intentions or a shift in control, introducing uncertainty for existing shareholders.

Key Numbers

• 10.0% — Beneficial Ownership (Indicates a significant stake in XWELL, Inc. by CPC Pain & Wellness SPV, LLC and associated individuals.)

Key Players & Entities

• CPC Pain & Wellness SPV, LLC (company) — Filing entity, beneficial owner of XWELL, Inc. stock
• XWELL, Inc. (company) — Subject company
• Wayne Mack (person) — Filing entity, beneficial owner of XWELL, Inc. stock
• Richard Waldo (person) — Filing entity, beneficial owner of XWELL, Inc. stock

FAQ

Key Financial Figures

• $0.01 — Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class o
• $1.6403 — hase Purchase of Common Stock 3,000 $1.6403 6/5/2024 Purchase of Common Stock 3
• $1.6574 — 2024 Purchase of Common Stock 3,000 $1.6574 6/6/2024 Purchase of Common Stock 3
• $1.6026 — 2024 Purchase of Common Stock 3,000 $1.6026 6/7/2024 Purchase of Common Stock 4
• $1.6799 — 024 Purchase of Common Stock 41,068 $1.6799 6/10/2024 Purchase of Common Stock
• $1.9073 — 024 Purchase of Common Stock 20,310 $1.9073 6/11/2024 Purchase of Common Stock
• $2.0691 — 024 Purchase of Common Stock 48,921 $2.0691 6/12/2024 Purchase of Common Stock
• $2.3456 — 024 Purchase of Common Stock 46,255 $2.3456 6/13/2024 Purchase of Common Stock
• $2.4972 — 024 Purchase of Common Stock 24,320 $2.4972 6/14/2024 Purchase of Common Stock
• $2.4950 — 2024 Purchase of Common Stock 4,326 $2.4950 6/17/2024 10 of 10

Filing Documents

• cpc240651_13d.htm (SC 13D) — 142KB
• cpc240651_ex99-1.htm (EX-99.1) — 12KB
• 0000897101-24-000234.txt ( ) — 156KB

Identity

Item 2. Identity and Background. (a) This Schedule 13D is being filed by: (i) CPC Pain & Wellness SPV, LLC (“CPC”), a Delaware limited liability company with respect to shares of Common Stock held directly by it; (ii) ACM-CPC, LLC (“ACM-CPC”), as the managing member of CPC; (iii) Wayne Mack, as the co-managing member of ACM-CPC; and (iv) Richard Waldo, as the co-managing member of ACM-CPC. Each of the foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons.” Each of the Reporting Persons is a party to that certain Joint Filing Agreement, as further described in Item 6. Accordingly, the Reporting Persons are hereby filing a joint Schedule 13D. (b) The address of the principal business office of (i) CPC is 301 Edgewater Place, Suite 100 Wakefield, MA 01880 and (ii) ACM-CPC, Mr. Mack and Mr. Waldo is 1500 District Avenue, Burlington, MA 01803. (c) The principal business of CPC is investing in securities. The principal business of ACM-CPC is acting as the managing member of CPC. The principal business of each of Mr. Mack and Mr. Waldo is serving as the managing member of ACM-CPC and managing investments. (d) During the last five years, none of the Reporting Persons have been convicted in a criminal proceeding (excluding traffic violations and similar misdemeanors). (e) During the last five years, none of the Reporting Persons have been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f) Each of CPC and ACM-CPC is a Delaware limited liability company. Mr. Mack is a citizen of the United States of America and South Africa. Mr. Waldo is a citizen of the United States of A

Source

Item 3. Source and Amount of Funds or Other Consideration. The shares of Common Stock purchased by CPC were purchased with working capital . The aggregate purchase price of the 394,200 shares of Common Stock directly owned by CPC (the “Shares”) was approximately $ 790,804.55 , including brokerage commissions.

Purpose

Item 4. Purpose of Transaction. The Reporting Persons purchased the Shares based on their belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Common Stock at prices that would make the purchase or sale of Common Stock desirable, the Reporting Persons may endeavor to increase or decrease its position in the Issuer through, among other things, the purchase or sale of Common Stock on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable. The Reporting Persons are concerned with the Issuer’s long-term underperformance and believe shareholder representation on the Board of Directors of the Issuer (the “Board”) and a change in the composition of the Board is necessary to drive significant improvements to the Issuer’s governance, capital allocation and operations, and to explore strategic alternatives. The Reporting Persons believe there are significant growth opportunities at the Issuer and remains available and ready to engage directly with the Board and management to discuss such opportunities. 6 of 10 Depending on various factors including, without limitation, the Issuer’s financial position and investment strategy, the price levels of the Common Stock, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate including, without limitation, engaging in communications with management and the Board, engaging in discussions with shareholders of the Issuer or third parties, including potential acquirers and service providers about the Issuer and the Reporting Persons’ investment, making proposals to the Issuer co

View Full Filing

View this SC 13D filing on SEC EDGAR